CD74-ROS1 fusion transcripts in resected non-small cell lung carcinoma.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Oncology Report

• Publication date

  2013-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2013.2630PMID 23877438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ROS1-Rearranged Lung Cancer: A Clinicopathologic and Molecular Study of 15 Surgical Cases

  2013cited by this paper
• Crizotinib: A New Treatment Option for ALK-Positive Non-Small Cell Lung Cancer

  2013cited by this paper
• ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLC

  2013cited by this paper
• The transcriptional landscape and mutational profile of lung adenocarcinoma

  2012cited by this paper
• Analysis of Receptor Tyrosine Kinase ROS1-Positive Tumors in Non–Small Cell Lung Cancer: Identification of a FIG-ROS1 Fusion

  2012cited by this paper
• Assessment of EGFR and K-ras mutations in fixed and fresh specimens from transesophageal ultrasound-guided fine needle aspiration in non-small cell lung cancer patients.

  2012cited by this paper
• Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer

  2012cited by this paper
• KIF5B/RET fusion gene in surgically-treated adenocarcinoma of the lung.

  2012cited by this paper
• KIF5B-RET fusions in lung adenocarcinoma

  2012cited by this paper
• Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

  2012cited by this paper
• RET, ROS1 and ALK fusions in lung cancer

  2012cited by this paper
• ROS1 rearrangements define a unique molecular class of lung cancers.

  2012cited by this paper
• Targeting Anaplastic Lymphoma Kinase in Lung Cancer

  2011cited by this paper
• Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• New driver mutations in non-small-cell lung cancer.

  2011cited by this paper
• Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma

  2010cited by this paper
• EML4-ALK fusion transcripts in immunohistochemically ALK-positive non-small cell lung carcinomas.

  2010cited by this paper
• EGFR/KRAS/BRAF Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node Metastases

  2009cited by this paper
• Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population

  2009cited by this paper
• EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas.

  2008cited by this paper
• Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.

  2007cited by this paper
• Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

  2007cited by this paper
• Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically

  1999cited by this paper

• Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges

  2024cites this paper
• Genome-wide Detection of Chimeric Transcripts in Early-stage Non-small Cell Lung Cancer

  2023cites this paper
• CD74–ROS1 L2026M mutant enhances autophagy through the MEK/ERK pathway to promote invasion, metastasis and crizotinib resistance in non‐small cell lung cancer cells

  2023cites this paper
• CD74 and HLA-DRA in Cervical Carcinogenesis: Potential Targets for Antitumour Therapy

  2022cites this paper
• Detection of ROS1 gene fusions using next-generation sequencing for patients with malignancy in China

  2022cites this paper
• Correlation of ROS1 (D4D6) Immunohistochemistry with ROS1 Fluorescence In Situ Hybridization Assay in a Contemporary Cohort of Pulmonary Adenocarcinomas

  2022cites this paper
• A novel CD74-ROS1 gene fusion in a patient with inflammatory breast cancer: a case report

  2021influential citation
• Determination of ROS1 positivity by immunohistochemistry in a multicentric cohort of 426 non-small-cell lung cancer cases in India

  2019cites this paper
• CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib.

  2018cites this paper
• Expression of CD74 in bladder cancer and its suppression in association with cancer proliferation, invasion and angiogenesis in HT-1376 cells

  2018cites this paper
• Basic Concepts of Fusion Genes and Their Classification

  2017cites this paper
• A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing.

  2016cites this paper
• Polymorphism of Rs9387478 Correlates with Overall Survival in Female Nonsmoking Patients with Lung Cancer

  2016cites this paper
• Emerging Biomarkers in Personalized Therapy of Lung Cancer.

  2016cites this paper
• CD44-SLC1A2 Fusion Transcripts in Primary Colorectal Cancer

  2015cites this paper
• Prognostic and predictive biomarkers in lung cancer. A review

  2014cites this paper
• Recent advances of cluster of differentiation 74 in cancer

  2014cites this paper
• A novel somatic FGFR3 mutation in primary lung cancer.

  2014cites this paper
• Redefining cancer: a new paradigm for better and faster treatment innovation.

  2014cites this paper
• From single-gene to multiplex analysis in lung cancer, challenges and accomplishments: a review of a single institution's experience.

  2014cites this paper
• A novel somatic FGFR 3 mutation in primary lung cancer

  2014cites this paper
• Review and Perspectives

  year unknowncites this paper